Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina
Overview
Affiliations
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein (Cas) is used by some bacteria and most archaea to protect against viral phage intrusion and has recently been adapted to allow for efficient editing of the mammalian genome. Whilst CRISPR/Cas-based technology has been used to modify genes in mammalian cells in vitro, delivery of CRISPR/Cas system into mammalian tissue and/or organs is more difficult and often requires additional vectors. With the use of adeno-associated virus (AAV) gene delivery system, active CRISPR/Cas enzyme can be maintained for an extended period of time and enable efficient editing of genome in the retina in vivo. Herein we outline the method to edit the genome in mouse retina using a dual AAV vector -mediated CRISPR/Cas9 system.
Vazquez-Dominguez I, Oktem M, Winkelaar F, Nguyen T, Hoogendoorn A, Roschi E Mol Ther Nucleic Acids. 2024; 35(4):102345.
PMID: 39494150 PMC: 11531624. DOI: 10.1016/j.omtn.2024.102345.
Fierro Jr J, Dipasquale J, Perez J, Chin B, Chokpapone Y, Tran A Sci Rep. 2022; 12(1):2417.
PMID: 35165339 PMC: 8844083. DOI: 10.1038/s41598-022-06430-1.
Gene-Based Therapeutics for Inherited Retinal Diseases.
Fenner B, Tan T, Barathi A, Tun S, Yeo S, Tsai A Front Genet. 2022; 12:794805.
PMID: 35069693 PMC: 8782148. DOI: 10.3389/fgene.2021.794805.
Comparison of CRISPR/Cas Endonucleases for Retinal Gene Editing.
Li F, Wing K, Wang J, Luu C, Bender J, Chen J Front Cell Neurosci. 2020; 14:570917.
PMID: 33132845 PMC: 7511709. DOI: 10.3389/fncel.2020.570917.
Li P, Kleinstiver B, Leon M, Prew M, Navarro-Gomez D, Greenwald S CRISPR J. 2019; 1:55-64.
PMID: 31021187 PMC: 6319323. DOI: 10.1089/crispr.2017.0009.